Robert Michael Poole - Jul 9, 2021 Form 3 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann For Robert Michael Poole by PoA
Stock symbol
OVID
Transactions as of
Jul 9, 2021
Transactions value $
$0
Form type
3
Date filed
7/12/2021, 05:07 PM
Next filing
Feb 4, 2022

No securities are beneficially owned.